San Diego, CA, United States of America

Mary Ann Pellymounter

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2011.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Ann Pellymounter: Innovator in Protein Composition

Introduction

Mary Ann Pellymounter is a distinguished inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of protein compositions. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing scientific knowledge.

Latest Patents

Mary Ann Pellymounter holds a patent for "OB fusion protein compositions and methods." This invention relates to Fc-OB fusion protein compositions, methods of preparation of such compositions, and their various uses. Specifically, it involves a genetic or chemical fusion protein that comprises the Fc immunoglobulin region, derivative, or analog fused to the N-terminal portion of the OB protein, derivative, or analog. This patent highlights her innovative approach to protein engineering and its potential applications in medicine.

Career Highlights

Throughout her career, Mary Ann has been associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her contributions to the field.

Collaborations

Mary Ann has worked alongside notable colleagues, including Michael B Mann and Randy Ira Hecht. These collaborations have played a crucial role in her research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Mary Ann Pellymounter is a remarkable inventor whose work in protein compositions has the potential to impact various scientific fields. Her dedication to innovation and collaboration continues to drive advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…